Theralase Technologies Inc. V.TLT

Alternate Symbol(s): TLTFF

Healthcare Medical Devices

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called Photo Dynamic Compounds (PDCs) and activates them with patent pending laser technology to destroy specifically targeted cancers, bacteria and viruses. The CLT division is responsible for the Company’s medical laser business. The Cool Laser Therapy division designs, develops, manufactures and markets super-pulsed laser technology indicated for the healing of chronic knee pain. The technology has been used off-label for healing numerous nerve, muscle and joint conditions. The Company develops products both internally and using the assistance of specialist external resources.

TSXV:TLT - Post by User

Theralase Technologies Inc. > 0.24 Seriously?

<< Previous

Bullboard Posts

Next >>

Comment by Lesalpes29on Nov 17, 2022 8:10am

137 Views

Post# 35106046

RE:RE:0.24 Seriously?

Infinity wrote: I am seriously concerned that TLT is not able to close a small follow up or by choosing not to disclose any information regarding the second PP, could be in violation of OSC filing requirement. It is nearly 45 days from the date of announcement 3rd Oct. Hoping they did their homework correctly before going into the follow up PP

They are probably very busy. Next financial report, closing the PP, BTD and the list is longer. Of course, the delay to close the last PP open the door to a lot of good or bad spculations! GL

<< Previous

Bullboard Posts

Next >>

Sirios Resource discovers visible gold in Quebec